GRAIL submitted the final PMA module to the FDA for its Galleri multi-cancer early detection blood test. The Galleri test holds FDA Breakthrough status, backed by U.S. PATHFINDER 2 results and the NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results